Back to Awarded Treatment Trials


Awarded Trial: 14T-006

This study randomized 120 patients with schizophrenia with elevated C-reactive protein to add-on 200g/d minocycline, 200 g/d doxycycline or placebo. No significant differences were detected between minocycline or doxycycline and placebo.

Grant ID

14T-006

Illness

Schizophrenia

Primary Drug/Intervention

Minocycline or Doxycycline

Primary Dosage

100 mg B.I.D.

Secondary Drug Intervention

antipsychotic drug treatment

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Weiser

Sample Size

210

Duration of Study Period for Each Subject

70 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Mark Weiser

Degree

MD

Center

N/A

Institution

N/A

Address

N/A

City or Town

N/A

State or Province

N/A

Zip or Postal Code

N/A

Country

USA

Email Address

N/A